Join to View Full Profile
3288 Illinois AveSuite 101Louisville, KY 40213
Phone+1 502-515-6621
Fax+1 502-515-6620
Are you Dr. Bays?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Harold Bays, MD is an endocrinologist in Louisville, Kentucky. He is currently licensed to practice medicine in Kentucky.
Education & Training
University of Louisville School of MedicineFellowship, Endocrinology, Diabetes, and Metabolism, 1987 - 1989- University of Louisville School of MedicineResidency, Internal Medicine, 1984 - 1987
- University of Louisville School of MedicineClass of 1984
Certifications & Licensure
KY State Medical License 1985 - 2026
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
American Board of Obesity Medicine Obesity Medicine
Publications & Presentations
PubMed
- 1 citationsEfficacy and safety of a novel oral hydrogel capsule in adults with overweight or obesity: the pivotal randomized RESET study.Jamy D Ard, Donna H Ryan, Patrick M O'Neil, Robert F Kushner, Holly R Wyatt
Obesity. 2025-03-01 - Bempedoic Acid for Prevention of Cardiovascular Events in People With Obesity: A CLEAR Outcomes Subset Analysis.Harold E Bays, LeAnne Bloedon, Danielle Brennan, Lei Lei, A Michael Lincoff
Journal of the American Heart Association. 2025-02-18 - 10 citationsOnce-Weekly Semaglutide in Persons with Obesity and Knee Osteoarthritis.Henning Bliddal, Harold Bays, Sébastien Czernichow, Joanna Uddén Hemmingsson, Jøran Hjelmesæth
The New England Journal of Medicine. 2024-10-31
Press Mentions
Harold Bays on Obesity, Dyslipidemia, and Cardiovascular DiseaseDecember 10th, 2024- Harold Bays on How T2DM Interferes with Weight Reduction in ObesityNovember 26th, 2024
- Harold Bays on OMA's Clinical Practice Statement on Obesity and Type 2 DiabetesNovember 1st, 2024
- Join now to see all
